CANCER-RELATED PROTEIN KINASES
    1.
    发明申请
    CANCER-RELATED PROTEIN KINASES 审中-公开
    癌相关蛋白激酶

    公开(公告)号:US20110008347A1

    公开(公告)日:2011-01-13

    申请号:US12517050

    申请日:2007-12-03

    摘要: The present invention relates to mutant kinase polypeptides and kinase variants selected from the group consisting of AATYK (AATK), ABL1, ACK1, ALK, ARG, AXL, BMX, BRK, BTK, CCK4, CSFR1, CSK, DDR1, DDR2, EGFR, EPHA1, EPHA2, EPHA3, EPHA4, EPHA5, EPHA6, EPHA7, EPHA10, EPHB1, EPHB2, EPHB3, EPHB4, EPHB6, FAK, FER, FES, FGFR1, FGFR2, FGFR4, FLT3, FRK, FYN, HER2, HER3, HER4, IGF1R, INSR, ITK, JAK1, JAK2, JAK3, LCK, LMTK2 (AATYK2/BREK), LYN, MATK, MER, MET, NTRK1, NTRK2, NTRK3, PDGRFA, PDGFRB, PTK-9, PYK2, RET, RON, ROR1, ROR2, ROS, RYK, STYK, SYK, TEC, TEK, TIE, TNK1, TXK, TYK2, TYRO3, VEGFR1, VEGFR2, VEGFR3, YES1, and ZAP70, nucleotide sequences encoding the mutant kinase polypeptides and kinase variants, as well as various products and methods useful for the diagnosis and treatment of various kinase-related diseases and conditions, including the screening for and identification of novel protein kinase modulators.

    摘要翻译: 本发明涉及选自AATYK(AATK),ABL1,ACK1,ALK,ARG,AXL,BMX,BRK,BTK,CCK4,CSFR1,CSK,DDR1,DDR2,EGFR的突变型激酶多肽和激酶变体, EPHA1,EPHA2,EPHA3,EPHA4,EPHA5,EPHA6,EPHA7,EPHA10,EPHB1,EPHB2,EPHB3,EPHB4,EPHB6,FAK,FER,FES,FGFR1,FGFR2,FGFR4,FLT3,FRK,FYN,HER2,HER3,HER4, IGF1R,INSR,ITK,JAK1,JAK2,JAK3,LCK,LMTK2(AATYK2 / BREK),LYN,MATK,MER,MET,NTRK1,NTRK2,NTRK3,PDGRFA,PDGFRB,PTK-9,PYK2,RET,RON,ROR1 ,ROR2,ROS,RYK,STYK,SYK,TEC,TEK,TIE,TNK1,TXK,TYK2,TYRO3,VEGFR1,VEGFR2,VEGFR3,YES1和ZAP70,编码突变型激酶多肽和激酶变体的核苷酸序列, 用于诊断和治疗各种激酶相关疾病和病症的各种产品和方法,包括筛选和鉴定新的蛋白激酶调节剂。